PGP and malignant colon neoplasm: Our previous study [28] demonstrated that isorhamnetin can modulate the expression of several drug-resistance-associated ABC transporters, including P-gp in DLD-1 and HCT-116 colon cancer cells, thereby influencing cellular drug efflux and resistance development.